title: Circadian rhythm disruption by a novel running wheel: roles of exercise and arousal in blockade of the luteinizing hormone surge.
abstract: Exposure of proestrous Syrian hamsters to a new room, cage, and novel running wheel blocks the luteinizing hormone (LH) surge until the next day in ~75% of hamsters [1]. The studies described here tested the hypotheses that 1) exercise and/or 2) orexinergic neurotransmission mediate novel wheel blockade of the LH surge and circadian phase advances. Female hamsters were exposed to a 14L:10D photoperiod and activity rhythms were monitored with infra-red detectors. In Expt. 1, to test the effect of exercise, hamsters received jugular cannulae and on the next day, proestrus (Day 1), shortly before zeitgeber time 5 (ZT 5, 7h before lights-off) the hamsters were transported to the laboratory. After obtaining a blood sample at ZT 5, the hamsters were transferred to a new cage with a novel wheel that was either freely rotating (unlocked), or locked until ZT 9, and exposed to constant darkness (DD). Blood samples were collected hourly for 2days from ZT 5-11 under red light for determination of plasma LH levels by radioimmunoassay. Running rhythms were monitored continuously for the next 10-14days. The locked wheels were as effective as unlocked wheels in blocking LH surges (no Day 1 LH surge in 6/9 versus 8/8 hamsters, P>0.05) and phase advances in the activity rhythms did not differ between the groups (P=0.28), suggesting that intense exercise is not essential for novel wheel blockade and phase advance of the proestrous LH surge. Expt. 2 tested whether orexin neurotransmission is essential for these effects. Hamsters were treated the same as those in Expt. 1 except that they were injected (i.p.) at ZT 4.5 and 5 with either the orexin 1 receptor antagonist SB334867 (15mg/kg per injection) or vehicle (25% DMSO in 2-hydroxypropyl-beta-cyclodextrin (HCD)). SB-334867 inhibited novel wheel blockade of the LH surge (surges blocked in 2/6 SB334867-injected animals versus 16/18 vehicle-injected animals, P<0.02) and also inhibited wheel running and circadian phase shifts, indicating that activation of orexin 1 receptors is necessary for these effects. Expt. 3 tested the hypothesis that novel wheel exposure activates orexin neurons. Proestrous hamsters were transferred at ZT 5 to a nearby room within the animal facility and were exposed to a new cage with a locked or unlocked novel wheel or left in their home cages. At ZT 8, the hamsters were anesthetized, blood was withdrawn, they were perfused with fixative and brains were removed for immunohistochemical localization of Fos, GnRH, and orexin. Exposure to a wheel, whether locked or unlocked, suppressed circulating LH concentrations at ZT 8, decreased the proportion of Fos-activated GnRH neurons, and increased Fos-immunoreactive orexin cells. Unlocked wheels had greater effects than locked wheels on all three endpoints. Thus in a familiar environment, exercise potentiated the effect of the novel wheel on Fos expression because a locked wheel was not a sufficient stimulus to block the LH surge. In conclusion, these studies indicate that novel wheel exposure activates orexin neurons and that blockade of orexin 1 receptors prevents novel wheel blockade of the LH surge. These findings are consistent with a role for both exercise and arousal in mediating novel wheel blockade of the LH surge.
authors.affiliation: Department of Anatomy and Neurobiology, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536-0298, United States. Electronic address: marilyn.duncan@uky.edu.
authors.forename: Marilyn J
authors.initials: MJ
authors.lastname: Duncan
authors.affiliation: Department of Anatomy and Neurobiology, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536-0298, United States.
authors.forename: Kathleen M
authors.initials: KM
authors.lastname: Franklin
authors.affiliation: Department of Physiology, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536-0298, United States.
authors.forename: Xiaoli
authors.initials: X
authors.lastname: Peng
authors.affiliation: Department of Physiology, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536-0298, United States.
authors.forename: Christopher
authors.initials: C
authors.lastname: Yun
authors.affiliation: Department of Physiology, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536-0298, United States.
authors.forename: Sandra J
authors.initials: SJ
authors.lastname: Legan
mesh_terms: D000818:Animals; D001143:Arousal / Q000502:physiology*; D001583:Benzoxazoles / Q000494:pharmacology; D002491:Central Nervous System Agents / Q000494:pharmacology; D002940:Circadian Rhythm / Q000187:drug effects / Q000502:physiology*; D003624:Darkness; D004971:Estrus / Q000187:drug effects / Q000502:physiology; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism; D006799:Housing, Animal; D007986:Luteinizing Hormone / Q000378:metabolism*; D008647:Mesocricetus; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology*; D009287:Naphthyridines; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D000068796:Orexin Receptor Antagonists; D064446:Orexin Receptors / Q000378:metabolism; D017440:Photoperiod; D011359:Proestrus / Q000187:drug effects / Q000502:physiology; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D014508:Urea / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: C420062:1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea; D001583:Benzoxazoles; D002491:Central Nervous System Agents; D009287:Naphthyridines; D000068796:Orexin Receptor Antagonists; D064446:Orexin Receptors; D016760:Proto-Oncogene Proteins c-fos; D007987:Gonadotropin-Releasing Hormone; D014508:Urea; D007986:Luteinizing Hormone
keywords: Circadian rhythms; Hypocretin; Luteinizing hormone; Novelty; Orexin; Phase shifts
references.citation: Bioorg Med Chem Lett. 2012 Nov 1;22(21):6661-4
references.pmid: 23031594
references.citation: J Neurosci. 2009 Nov 18;29(46):14423-38
references.pmid: 19923277
references.citation: Endocrinology. 2012 Jun;153(6):2839-50
references.pmid: 22454148
references.citation: Neuroendocrinology. 1980 Aug;31(2):147-57
references.pmid: 6771669
references.citation: Brain Res. 2010 Feb 16;1314:74-90
references.pmid: 19815001
references.citation: Eur J Neurosci. 2009 Oct;30(8):1603-14
references.pmid: 19811530
references.citation: J Biol Rhythms. 2003 Aug;18(4):307-17
references.pmid: 12932083
references.citation: Nature. 1989 May 4;339(6219):49-51
references.pmid: 2654641
references.citation: Endocrinology. 1974 May;94(5):1295-9
references.pmid: 4856727
references.citation: Biochem Biophys Res Commun. 2001 Feb 16;281(1):232-6
references.pmid: 11178985
references.citation: Chronobiol Int. 2008 Jul;25(4):625-43
references.pmid: 18622820
references.citation: Cell. 1998 Mar 6;92(5):1 page following 696
references.pmid: 9527442
references.citation: Brain Res Bull. 1998 Nov 1;47(4):367-76
references.pmid: 9886789
references.citation: Biochem Biophys Res Commun. 1999 Nov 2;264(3):759-62
references.pmid: 10544004
references.citation: J Comp Physiol A. 1998 Feb;182(2):251-8
references.pmid: 9463922
references.citation: J Comp Physiol A. 1989 Oct;165(6):811-8
references.pmid: 2810151
references.citation: Am J Physiol Regul Integr Comp Physiol. 2009 May;296(5):R1620-30
references.pmid: 19297538
references.citation: J Comp Neurol. 2006 Jan 1;494(1):190-214
references.pmid: 16304687
references.citation: J Hum Ergol (Tokyo). 1994 Dec;23(2):121-31
references.pmid: 7730597
references.citation: J Neurosci. 2001 Mar 1;21(5):1656-62
references.pmid: 11222656
references.citation: Horm Metab Res. 1999 Nov;31(11):606-9
references.pmid: 10598828
references.citation: Regul Pept. 2002 Mar 15;104(1-3):145-51
references.pmid: 11830289
references.citation: Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10911-6
references.pmid: 10485925
references.citation: J Neuroendocrinol. 2007 Sep;19(9):732-8
references.pmid: 17680889
references.citation: J Biol Rhythms. 2010 Dec;25(6):450-9
references.pmid: 21135161
references.citation: J Neurosci. 2000 Dec 15;20(24):9326-32
references.pmid: 11125012
references.citation: J Chem Neuroanat. 2001 May;21(3):225-38
references.pmid: 11382534
references.citation: PLoS One. 2011 Apr 13;6(4):e18395
references.pmid: 21533241
references.citation: Endocrinology. 1975 Apr;96(4):928-33
references.pmid: 1168126
references.citation: Science. 1985 May 17;228(4701):898-900
references.pmid: 4001926
references.citation: J Natl Cancer Inst. 2001 Oct 17;93(20):1563-8
references.pmid: 11604480
references.citation: Biol Rev Camb Philos Soc. 1996 Aug;71(3):343-72
references.pmid: 8761159
references.citation: Occup Med (Lond). 2003 Mar;53(2):103-8
references.pmid: 12637594
references.citation: Acta Physiol (Oxf). 2010 Mar;198(3):203-8
references.pmid: 19473132
references.citation: Brain Res. 2001 Apr 13;898(1):166-70
references.pmid: 11292461
references.citation: Neuron. 2005 Jun 2;46(5):787-98
references.pmid: 15924864
references.citation: Am J Physiol. 1991 Nov;261(5 Pt 2):R1109-17
references.pmid: 1951758
references.citation: J Neurosci. 2003 Aug 13;23(19):7412-4
references.pmid: 12917377
references.citation: Neuroreport. 2000 Jun 26;11(9):1977-80
references.pmid: 10884055
references.citation: Neuroscience. 2006 Jun 19;140(1):305-20
references.pmid: 16549274
references.citation: Endocrinology. 2003 Jul;144(7):3225-36
references.pmid: 12810579
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4453-8
references.pmid: 19255424
references.citation: Eur J Neurosci. 2008 Feb;27(4):828-35
references.pmid: 18279358
references.citation: Nat Neurosci. 2001 Jul;4(7):732-8
references.pmid: 11426230
references.citation: Health Care Women Int. 2002 Sep-Nov;23(6-7):703-14
references.pmid: 12418990
references.citation: Proc Natl Acad Sci U S A. 1990 Jul;87(13):5163-7
references.pmid: 2114646
references.citation: Horm Behav. 1981 Dec;15(4):451-8
references.pmid: 7199019
references.citation: J Neurosci. 1998 Dec 1;18(23):9996-10015
references.pmid: 9822755
references.citation: Am J Physiol Regul Integr Comp Physiol. 2003 Oct;285(4):R917-25
references.pmid: 12842864
references.citation: Nat Med. 2010 Jan;16(1):111-5
references.pmid: 20037593
references.citation: Endocrinology. 2003 Apr;144(4):1542-8
references.pmid: 12639939
references.citation: Peptides. 1986 Jan-Feb;7(1):155-9
references.pmid: 3520509
references.citation: Regul Pept. 1998 Nov 30;78(1-3):133-6
references.pmid: 9879756